enses for the quarter totaled $967,000, an increase of 58%, compared with $612,000 for the same period a year ago. In addition to the business expansion, the increase in operating expenses was attributable to a $0.2 million increase in G&A expenses associated with increased R&D related to oxygen and respiratory products, and, expenses associated with being a publicly traded company, including costs of maintaining and enhancing our internal controls, and a $0.1 million increase in selling expenses for marketing and network building.
Net IncomeNet income attributable to the Company for the three months ended June 30, 2011 was $1.7 million, compared with $1.1 million for the three months ended June 30, 2010. The increase in net income was primarily due to robust top line growth. Earnings per diluted share were $0.39, based on 4.5 million shares outstanding for the quarter, compared with diluted EPS of $0.27, based on 4.3 million shares outstanding for the second quarter of 2010.
Liquidity and Capital ResourcesAs of June 30, 2011, Dehaier had $3.0 million in cash and cash equivalents, compared with $5.9 million as of December 31, 2010. The decrease was primarily to the result of an increase in prepayments due to more distribution agreements requiring prepayment for products. Current assets totaled $39.0 million, with working capital of $25.1 million and total shareholders' equity of $27.0 million at June 30, 2011, respectively.
Conference Call and WebcastManagement will host a conference call to discuss these financial results on Monday, August 15, 2011 at 8:00 a.m. EDT.
To participate in the call please dial (877) 941-8416 in the U.S. and Canada, or (480) 629-9808 for international calls, approximately 10 minutes prior to the scheduled start time. Interested parties can also listen via a live Internet webcast, which can be found on the Company's website at http://www.china
Page: 1 2 3 4 5 6 7 8 9 10 Related medicine technology :1
|SOURCE Dehaier Medical Systems Ltd.|
Copyright©2010 PR Newswire.
All rights reserved
. Dehaier Medical to Report Second Quarter 2011 Financial Results on August 152
. Dehaier Opens First Oxygen Filling Facility and First Service Center for Home Oxygen Therapy Service in Beijing3
. Dehaier Medical Systems Names Dr. Xiaoqing Wang New Chief Technology Officer4
. Dehaier Strengthens Intellectual Property Portfolio5
. Dehaier Awarded $1.32 Million Procurement Contract to Supply Medical Devices to Hospital 301 in Beijing6
. Dehaier Medical Announces First Quarter 2011 Financial Results7
. Dehaier Medical to Report First Quarter 2011 Financial Results on May 48
. Dehaier Medical Chairman and CEO Issues Letter to Shareholders9
. Dehaier Medical Systems Signs New Distribution Agreement to Distribute eVent Medical Ventilators10
. Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results11
. Dehaier Medical to Report Fourth Quarter and Full-Year 2010 Financial Results on March 7